×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CGEM – cullinan therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CGEM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
12:16 pm
cgem
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
Low
Report
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
4/16
07:00 am
cgem
Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis
Low
Report
Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis
3/7
12:26 pm
cgem
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $35.00 price target on the stock, down previously from $38.00.
Low
Report
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $35.00 price target on the stock, down previously from $38.00.
2/28
08:13 am
cgem
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
High
Report
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
2/27
07:00 am
cgem
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Low
Report
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
2/24
07:00 am
cgem
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
1/30
07:00 am
cgem
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
Medium
Report
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
1/29
01:21 pm
cgem
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) had its price target raised by analysts at HC Wainwright from $28.00 to $33.00. They now have a "buy" rating on the stock.
Medium
Report
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) had its price target raised by analysts at HC Wainwright from $28.00 to $33.00. They now have a "buy" rating on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/27
05:00 pm
cgem
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: SUMER JACQUELYN L
Low
Report
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: SUMER JACQUELYN L
2/27
05:00 pm
cgem
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: Michaelson Jennifer
Low
Report
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: Michaelson Jennifer
2/27
05:00 pm
cgem
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: AHMED NADIM
Low
Report
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: AHMED NADIM
2/27
05:00 pm
cgem
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: Jones Jeffrey Alan
Low
Report
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: Jones Jeffrey Alan
2/27
07:12 am
cgem
Form S-8 Cullinan Therapeutics,
Low
Report
Form S-8 Cullinan Therapeutics,
2/27
07:07 am
cgem
Form 10-K Cullinan Therapeutics, For: Dec 31
Low
Report
Form 10-K Cullinan Therapeutics, For: Dec 31
2/27
07:03 am
cgem
Form 8-K Cullinan Therapeutics, For: Feb 27
Low
Report
Form 8-K Cullinan Therapeutics, For: Feb 27
2/21
06:00 pm
cgem
Form 4 Cullinan Therapeutics, For: Feb 19 Filed by: AHMED NADIM
Medium
Report
Form 4 Cullinan Therapeutics, For: Feb 19 Filed by: AHMED NADIM
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: